Remove Clinical Pharmacology Remove Clinical Trials Remove Organic Chemistry
article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

In clinical trials, the highest dose was set at 960 mg; whilst judged to be well-tolerated, 45 percent of patients receiving this dose showed serious complications and 7 percent had to stop treatment. Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London. 2021 Jul 8;110(5):1216–30.